| The landscape of entrepreneurship in life sciences has several unique characteristics - widely varying risk profiles, a close relationship to academia, evolving regulatory regimes, the potential for great societal good, and, especially today, a very challenging funding environment. Jeff, who began his career as an accidental entrepreneur in information technology in the early 90's, has been exploring this landscape from a variety of perspectives and will share his travelogue to date. Of particular interest is the intersection between entrepreneurship, academia, and life science enterprises and how important science gets translated into clinical and commercial practice. This talk will touch on several different models of life science translational entrepreneurship and discuss a set of still-open questions and emerging challenges. About the Speaker: Jeffrey S. Behrens Jeff is the Director of Strategic Alliances at Alnylam Pharmaceuticals. Before joining Alnylam, Jeff was the Head of Business Operations of BI3 - The Biogen Idec Innovation Incubator. Previously, Jeff founded The Telluride Group, an IT managed services company, which was successfully sold to mindSHIFT Technologies, a Fidelity roll-up, in late 2003. From 2004-2006, Jeff consulted with a number of biotechnology venture capital firms while completing graduate work at MIT and Harvard Medical School. Jeff is also an angel investor and a member MIT's Venture Mentoring Service. He serves on the boards of the Boston Museum of Science, Harvard/MIT HST Alumni Association, and Finale Desserts.
Columbia Technology Ventures is the technology transfer office of Columbia University. Throughout the year, we host and promote a variety of events relating to technology, entrepreneurship, and intellectual property. To join our mailing list, please visit our website at www.techventures.columbia.edu or send us an email at techventures@columbia.edu. See you at our next event! |